parion.com

Parion Sciences

CFTR Corrector Program for CF. P-321 Dry Eye Disease. Parion Sciences is a development stage company dedicated to research, development, and commercialization of treatments to restore patient’s innate mucosal surface defenses. The epithelial surface plays an important role in keeping our bodies healthy. Parion’s science driven technologies target respiratory, ocular and other epithelial diseases resulting from deficiencies of the innate host defenses. CFTR Corrector Program for CF. P-321 Dry Eye Disease.

http://www.parion.com/

OVERVIEW OF parion.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PARION.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.3 out of 5 with 8 reviews

5 star

4

4 star

2

3 star

2

2 star

0

1 star

0

Hey there! Start your review of parion.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.7 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128
160x160
192x192

CONTACTS AT PARION.COM

Parion Sciences, Inc.

Parion Sciences, Inc. unknown

Suite 260 ●●●●●●●●●●an Parkway

Du●●am , NC, 27713

AF

93.9●●●●1180

93.9●●●●1190

pb●●●●●●@parion.com

View this contact

Parion Sciences, Inc.

Parion Sciences, Inc. unknown

Suite 260 ●●●●●●●●●●an Parkway

Du●●am , NC, 27713

AF

93.9●●●●1180

93.9●●●●1190

pb●●●●●●@parion.com

View this contact

Parion Sciences, Inc.

Parion Sciences, Inc. unknown

Suite 260 ●●●●●●●●●●an Parkway

Du●●am , NC, 27713

AF

93.9●●●●1180

93.9●●●●1190

pb●●●●●●@parion.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2000 December 11
UPDATED: 2013 December 10
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

24

YEARS
6

MONTHS
13

DAYS

NAME SERVERS

1: ns1.mediatemple.net
2: ns2.mediatemple.net

REGISTRAR

DOMAIN.COM, LLC

WHOIS : whois.domain.com

REFERRED : http://www.domain.com

CONTENT

PAGES IN
THIS WEBSITE

15

SSL

EXTERNAL LINKS

5

SITE IP

192.124.249.10

LOAD TIME

1.672 sec

SCORE

6.2

PAGE TITLE

Parion Sciences | parion.com Reviews

<META> DESCRIPTION

CFTR Corrector Program for CF. P-321 Dry Eye Disease. Parion Sciences is a development stage company dedicated to research, development, and commercialization of treatments to restore patient’s innate mucosal surface defenses. The epithelial surface plays an important role in keeping our bodies healthy. Parion’s science driven technologies target respiratory, ocular and other epithelial diseases resulting from deficiencies of the innate host defenses. CFTR Corrector Program for CF. P-321 Dry Eye Disease.

<META> KEYWORDS

1 menu

2 skip to content

3 management team

4 board of directors

5 pipeline

6 tpad

7 mucolytic agents

8 clinical trials

9 news and events

10 partnerships

CONTENT

Page content here

KEYWORDS ON PAGE

menu,skip to content,management team,board of directors,pipeline,tpad,mucolytic agents,clinical trials,news and events,partnerships,careers,search for,parion sciences,bout,clinialtrialsslide,newsslide,learn more…,about parion,about us,recent posts,meta

SERVER

Sucuri/Cloudproxy

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Parion Sciences | parion.com Reviews

https://parion.com

CFTR Corrector Program for CF. P-321 Dry Eye Disease. Parion Sciences is a development stage company dedicated to research, development, and commercialization of treatments to restore patient’s innate mucosal surface defenses. The epithelial surface plays an important role in keeping our bodies healthy. Parion’s science driven technologies target respiratory, ocular and other epithelial diseases resulting from deficiencies of the innate host defenses. CFTR Corrector Program for CF. P-321 Dry Eye Disease.

INTERNAL PAGES

parion.com

1

Mucolytic Agents | Parion Sciences

http://www.parion.com/pipeline/mucolytic-agents

P-1037 for Pulmonary Disease (Clean-CF). CFTR Corrector Program for CF. P-321 Dry Eye Disease. Mucolytic Agents for Respiratory Diseases. Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease. Parion Sciences Announces the Presentation of Clinical Data on P-321 Ophthalmic Solution for the treatment of Dry Eye Disease at the Association for Research in Vision and Ophthalmology (ARVO 2016).

2

News and Events | Parion Sciences

http://www.parion.com/news-and-events

P-1037 for Pulmonary Disease (Clean-CF). CFTR Corrector Program for CF. P-321 Dry Eye Disease. Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease. July 26, 2016. First Patient Enrolled in P-321-202 Clinical Trial. Durham, NC (July 26, 2016). READ THE ENTIRE PRESS RELEASE HERE. May 2, 2016. Data on P-321 from clinical research to be presented on May 3rd. Durham, NC (May 2, 2016). READ THE ENTIRE PRESS RELEASE HERE. January 19, 2016. October 5, 2015.

3

Vertex and Parion Sciences Establish Collaboration to Develop Epithelial Sodium Channel (ENaC) Inhibitors in Cystic Fibrosis and Other Pulmonary Diseases | Parion Sciences

http://www.parion.com/news-and-events/vertex-and-parion-sciences-establish-collaboration-to-develop-epithelial-sodium-channel-enac-inhibitors-in-cystic-fibrosis-and-other-pulmonary-diseases

P-1037 for Pulmonary Disease (Clean-CF). CFTR Corrector Program for CF. P-321 Dry Eye Disease. Vertex and Parion Sciences Establish Collaboration to Develop Epithelial Sodium Channel (ENaC) Inhibitors in Cystic Fibrosis and Other Pulmonary Diseases. June 5, 2015. 8211; ENaC inhibition aims to restore or improve hydration of cell surfaces in the lungs to improve lung. 8211; Parion to receive $80 million up-front payment with potential for additional development and regulatory. BOSTON and DURHAM, NC.

4

P-321 Dry Eye Disease | Parion Sciences

http://www.parion.com/pipeline/p-321-dry-eye

P-1037 for Pulmonary Disease (Clean-CF). CFTR Corrector Program for CF. P-321 Dry Eye Disease. P-321 Dry Eye Disease. P-321 FOR DRY EYE DISEASE. Dry Eye Disease Overview. P-321 for Dry Eye Disease. Parion Sciences Announces Initiation of Phase 2 Clinical Trial of P-321 for the Treatment of Dry Eye Disease. Parion Sciences Announces the Presentation of Clinical Data on P-321 Ophthalmic Solution for the treatment of Dry Eye Disease at the Association for Research in Vision and Ophthalmology (ARVO 2016).

5

Parion Sciences Announces $3 Million Award from Cystic Fibrosis Foundation Therapeutics to Accelerate the Development of Novel CF Treatment | Parion Sciences

http://www.parion.com/news-and-events/parion-sciences-announces-3-million-award-from-cystic-fibrosis-foundation-therapeutics-to-accelerate-the-development-of-novel-cf-treatment

P-1037 for Pulmonary Disease (Clean-CF). CFTR Corrector Program for CF. P-321 Dry Eye Disease. Parion Sciences Announces $3 Million Award from Cystic Fibrosis Foundation Therapeutics to Accelerate the Development of Novel CF Treatment. September 16, 2014. Parion Sciences, President. Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis. Durham, NC (September 16, 2014). READ THE ENTIRE PRESS RELEASE HERE. Parion Sciences Ann...

UPGRADE TO PREMIUM TO VIEW 10 MORE

TOTAL PAGES IN THIS WEBSITE

15

LINKS TO THIS WEBSITE

cambridgeconsultants.com

Novel saltwater treatment device

http://www.cambridgeconsultants.com/news/pr/release/130/en

What sets us apart. Human Factors and Industrial Design. Radio and RF Systems. Signal Processing and Algorithms. 039;Interface' Magazine. Graduates, students and interns. Applying to work at CC. Wanted - exceptional engineers. Novel saltwater treatment device. Novel saltwater treatment device. Cambridge Consultants develops innovative nebuliser to treat cystic fibrosis. And the results have exceeded our expectations. CF is a chronic disease that affects the lungs and digestive system of more than 70,000 ...

anthelmette.wordpress.com

Accord sur le P-680, inhibiteur du canal sodique épithélial (ENaC) | Mucoviscidose

https://anthelmette.wordpress.com/2007/08/17/accord-sur-le-p-680-inhibiteur-du-canal-sodique-epithelial-enac

Accord sur le P-680, inhibiteur du canal sodique épithélial (ENaC). Août 17, 2007 · Filed under Uncategorized. Au fil du net … Un intéressant accord signé à la mi-août. DURHAM, Caroline du Nord and FOSTER CITY, Californie — (BUSINESS WIRE). Les sociétés Parion Sciences, Inc. et Gilead Sciences, Inc. (Nasdaq:GILD) ont annoncé aujourd’hui la signature d ’. Un accord exclusif de licence et de co-développement portant sur P-680, un inhibiteur du canal sodique. Selon les termes de l ’. Hydratation des surface...

bronchiectasisnewstoday.com

Vertex and Parion Sciences join efforts to develop Epithelial Sodium Channel (ENaC) Inhibitors for Cystic Fibrosis and Other Pulmonary Diseases

http://bronchiectasisnewstoday.com/2015/06/09/vertex-parion-sciences-join-efforts-develop-epithelial-sodium-channel-enac-inhibitors-cystic-fibrosis-pulmonary-diseases

This is a short description about myself and what this site is about. I hope you enjoy being here! Vertex and Parion Sciences Join Efforts to Develop Epithelial Sodium Channel (ENaC) Inhibitors for Cystic Fibrosis and Other Pulmonary Diseases. June 9, 2015. June 9, 2015. By Ana Pamplona, PhD. Click here to receive Bronchiectasis News via E-mail. Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical Officer at Vertex said in the news release. Presently, Parion is evaluating P-1037 by inhal...

anthelmette.wordpress.com

août | 2007 | Mucoviscidose

https://anthelmette.wordpress.com/2007/08

Archive for août, 2007. Accord sur le P-680, inhibiteur du canal sodique épithélial (ENaC). Août 17, 2007 · Filed under Uncategorized. Au fil du net … Un intéressant accord signé à la mi-août. DURHAM, Caroline du Nord and FOSTER CITY, Californie — (BUSINESS WIRE). Les sociétés Parion Sciences, Inc. et Gilead Sciences, Inc. (Nasdaq:GILD) ont annoncé aujourd’hui la signature d ’. Un accord exclusif de licence et de co-développement portant sur P-680, un inhibiteur du canal sodique. Selon les termes de l ’.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

5

OTHER SITES

pariomedia.com

ParioMedia.com

The site is under construction. Please check back shortly.

pariomira.com

Pariomira Creative Design Studios

Content on this page requires a newer version of Adobe Flash Player.

parion-web.info

派遣で働こう｜派遣で事務の仕事を始めよう！

parion.biz

Home

Lokalizasyon ve Siyasi Tarihi. Araştırma ve İlk Kazılar. Sedat - Naciye NUROVA Parion Kazı Evi. 1999 Yılı Yüzey Araştırması. 2002 Yılı Yüzey Araştırması. 2005 Kazı Sonuç Raporu. 2006 Kazı Sonuç Raporu. 2007 Kazı Sonuç Raporu. 2008 Kazı Ekibi Listesi. 2008 Kazı Sonuç Raporu. 2009 Kazı Sonuç Raporu. 2010 Kazı Ekibi Listesi. 2010 Kazı Sonuç Raporu. 2011 Kazı Sonuç Raporu. 2012 Kazı Sonuç Raporu. 2013 Kazı Ekibi Listesi. 2015 Kazı Sonuç Raporu. 2016 Kazı Sonuç Raporu. 2017 Kazı Sonuç Raporu. Vatanımızın savu...

parion.ca

Home page for Parion Animal Nutrition in Hickson Ontario.

Our hours are Monday - Saturday. 8 am - 5 pm. Join us in the conversation. T - 519.462.2222. Canada, N0J 1L0. At Parion Animal Nutrition, we challenge ourselves to make a difference every day,. And strive to propel the agricultural industry forward. Find out more about our us here. Whether a livestock farmer, hobby farmer or pet owner, we supply the highest quality of nutritional products, as well as premium services for whatever your needs. Click here to learn more. From our TruServ catalogue.

parion.com

Parion Sciences

CFTR Corrector Program for CF. P-321 Dry Eye Disease. Parion Sciences is a development stage company dedicated to research, development, and commercialization of treatments to restore patient’s innate mucosal surface defenses. The epithelial surface plays an important role in keeping our bodies healthy. Parion’s science driven technologies target respiratory, ocular and other epithelial diseases resulting from deficiencies of the innate host defenses. CFTR Corrector Program for CF. P-321 Dry Eye Disease.

parion.com.tr

Parion Gözetim Hizmetleri Ltd. Şti.

Maden ve Mineral Maddelerin Gözetimi. Araç (Kara) Kontrolleri Gözetimi. Manyetik Partikül Testi (MT). Sıvı Penetrant Testi (PT). Tahribatsız Muayene Personeli Kalifikasyonu. Kaldırma Ekipmanları ve Basınçlı Kaplar. Kaldırma Ekipmanları Periyodik Kontrolleri. Basınçlı Kaplar Periyodik Kontrolleri. Periyodik Kontrol Öncesi Yapılması Gereken Ön Hazırlıklar. ON HIRE / OFF HIRE. RÜZGAR GÜLLERİ AED PERİYODİK KONTROL. PARION TÜRKAK AKREDİTASYON KAPSAMI. AGFD GÖZETİM KURULUŞLARI DERNEĞİ.

pariona.blogspot.com

Trabajo de Photohosp CS3

Trabajo de Photohosp CS3. Miércoles, 10 de noviembre de 2010. Clase 4 Imagen 4. Enviar por correo electrónico. Clase 4 Imagen 3. Enviar por correo electrónico. Clase 4 Imagen 2. Enviar por correo electrónico. Clase 4 Imagen 1. Enviar por correo electrónico. Practica Nº 1 imagenes de web. Enviar por correo electrónico. Suscribirse a: Entradas (Atom). Clase 4 Imagen 4. Clase 4 Imagen 3. Clase 4 Imagen 2. Clase 4 Imagen 1. Practica Nº 1 imagenes de web. Ver todo mi perfil.

pariona.com

www.pariona.com

Diseño Gráfico. Gracias por la comprensión esta página está en construcción. Diseño Gráfico. Revistas y Catálogos. Algunos de nuestros trabajos.

parionainvesments.com

Elmer Pariona - Real Estate - Elmer Pariona

Real Estate - Elmer Pariona. ELMER PARIONA – REAL ESTATE INVESTOR. HOUSE FOR SALE GAUTIER MS. Built-in Bootstrap Elements let you do amazing things with your website. Easy to use control panel with a lot of options. Fully responsive theme for any device. Sorry, but you are looking for something that isn't here. This is a simple hero unit, a simple jumbotron-style component for calling extra attention to featured content or information. You got an error! Best check yo self, you're not looking too good.

parionaleng-wilber.blogspot.com

Electronics

Jueves, 14 de diciembre de 2006. Proyecto de Investigación acerca de la Robótica. Breve Evolución de la Robótic. Durante los siglos XVII y XVIII en Europa fueron construidos muñecos mecánicos muy ingeniosos que tenían algunas características de robots. Jacques de Vauncansos construyó varios músicos de tamaño humano a mediados del siglo XVIII. Esencialmente se trataba de robots mecánicos diseñados para un propósito específico: la diversión. 191; Qué es la Robótica? Clasificación de la Robótica. 1- Robots ...